Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt - MarketWatch
Teva tumbles as sales and earnings underwhelm
Teva Pharmaceutical Industries Ltd. Meets Earnings Targets Despite a Mild European Winter | The Motley Fool
Teva Pharmaceutical Industries Limited 2018 Q2 - Results - Earnings Call Slides (NYSE:TEVA) | Seeking Alpha
Teva Earnings: Is It Time to Worry? | Barron's
Teva Pharmaceutical beats Q4 earnings, sales estimates - Drug Delivery Business
Teva gains on earnings beat
TEVA Stock | Teva Pharmaceuticals Q2 2020 Earnings Call - YouTube
Here's Why Teva Shares are Trending Higher Today
Teva Pharmaceutical earnings per share 2006-2021 | Statista
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations - Simply Wall St News
Teva Pharmaceuticals Q4 2016 Earnings
TEVA PHARMACEUTICAL INDUSTRIES LIMITED TEVA EPS ANALYSIS
Teva reports jump in first-quarter earnings, raises guidance | The Times of Israel
Teva Pharmaceutical falls 6% on eve of Q3 earnings show | Seeking Alpha
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet
Teva earnings Q2 2018 | AlphaStreet
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
Teva Pharmaceuticals on Twitter: "Our live Q2 2022 earnings call is starting soon! Join President & CEO Kåre Schultz to discuss Teva's business performance and plans ahead. Join here: https://t.co/VR9FyBqEz2 #QuarterlyResults #Earnings $
Teva Pharmaceutical: Earnings Trends and Recent Developments
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
Teva ADR Earnings, Revenue Miss in Q3 By Investing.com
Q3 pharma earnings roundup: Moderna, Regeneron and Teva
Earnings season continues: BMS revenue inches up, Teva lowers outlook
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror – PharmaLive
